Biotech has been one of the worst-performing industry groups this cycle. Investors have got used to it as these stocks have been dead money for much of the past decade.
We're back with another commodity post in the Commodity Check series. Today we're highlighting a commodity that had quite a meteoric rise since November 2021. In February this year, we saw the price consolidate sideways. But guess what? We have a...
The Fed was all over the news this week, going out of its way to telegraph to the market its intention to pursue an accelerated pace of rate hikes. Fed funds futures seem to be getting the message. A...
I got a message last night that Ned Davis is retiring from the eponymous firm he launched more than four decades ago. Turns out, he’s not quite retiring – but he is stepping back. Either way, it’s a...
As sophisticated as public markets can be, they often have little quirks.
Everyone's heard about the McRib indicator: The S&P 500 has a higher daily return when the McRib is available at McDonald's than when it's not available.
For this week's trade, we're selling an $XLI May 97/105 Strangle for approximately $2.85 net credit. This means we're naked short both the 97 puts and the 105 calls.
Get the full details, risk management procedures and targets for this trade...
